Gallery
Picture 1
Govx stock forecast 2025 buy-side sentiment on GOVX stock
New with box
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Buy-side sentiment on GOVX stock forecast 2025 improved after Q1 2024 showing stronger-than-expected trial recruitment metrics, which boost confidence in meeting R&D timelines. 4 days ago · Stock forecasts and analyst price target predictions for GeoVax Labs, Inc. (GOVX) stock , with detailed revenue and earnings estimates. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiol Therapeutics wasn't on the list. GOVX stock forecast 2025 leverages competitive positioning within the infectious disease segment. Analysts cite projected market expansion of 9% CAGR in related biotech verticals as a supportive backdrop.